TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T30803	Glutathione reductase	D0Y3DN	Flavonoid derivative 4	Patented	5280343	C15H10O7	302.23	C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O)O	IC50 = 218000 nM	Non binder
T30803	Glutathione reductase	B2MV8P	Nitrobenzene	Investigative	7416	C6H5NO2	123.11	C1=CC=C(C=C1)[N+](=O)[O-]	Ki = 274100 nM	Non binder
T30803	Glutathione reductase	B98WSG	1-(4-Chlorophenyl)-3-morpholin-4-ylpropan-1-one	Investigative	723918	C13H16ClNO2	253.72	C1COCCN1CCC(=O)C2=CC=C(C=C2)Cl	IC50 > 212000 nM	Non binder
T30803	Glutathione reductase	BAU02I	3-(2-Chlorophenothiazin-10-yl)propyl-[(4-chlorophenyl)methyl]-dimethyl-ammonium	Investigative	11798906	C24H25Cl2N2S+	444.4	C[N+](C)(CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl)CC4=CC=C(C=C4)Cl	Ki = 2200000 nM	Non binder
T30803	Glutathione reductase	BHC23G	N-(Cyclohexylmethyl)-N,N-dimethyl-3-(2-chloro-10H-phenothiazine-10-yl)propane-1-aminium	Investigative	10791392	C24H32ClN2S+	416	C[N+](C)(CCCN1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl)CC4CCCCC4	Ki = 2000000 nM	Non binder
T30803	Glutathione reductase	BP0EU3	(E)-3-(3,4-Dihydroxy-phenyl)-N-[3-(4-{3-[(E)-3-(3,4-dihydroxy-phenyl)-acryloylamino]-propylamino}-butylamino)-propyl]-acrylamide	Investigative	44315802	C28H38N4O6	526.6	C1=CC(=C(C=C1/C=C/C(=O)NCCCNCCCCNCCCNC(=O)/C=C/C2=CC(=C(C=C2)O)O)O)O	Ki > 10000000 nM	Non binder
T30803	Glutathione reductase	BRZX94	(2E,5E)-2,5-Bis[[4-(azidomethyl)phenyl]methylidene]cyclopentan-1-one	Investigative	76317389	C21H18N6O	370.4	C1/C(=C\\C2=CC=C(C=C2)CN=[N+]=[N-])/C(=O)/C(=C/C3=CC=C(C=C3)CN=[N+]=[N-])/C1	IC50 = 228000 nM	Non binder
T30803	Glutathione reductase	D0O2DQ	Mepacrine	Investigative	237	C23H30ClN3O	400	CCN(CC)CCCC(C)NC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC	IC50 > 1000000 nM	Non binder